Octreotide

BYNFEZIA Pen, Mycapssa, Octreotide, Sandostatin, Sandostatin LAR Depot

Somatostatin Analog

NADAC/unit $2.6422

No Shortage Tier 1: 97.9% PA Req: 376.3% 9 Manufacturers 38 ANDAs

vs. brand BYNFEZIA Pen: Generic saves up to 74% per unit

Covered Lives

Generic Manufacturers

CHIESI FARMACEUTICI SPAFRESENIUS KABI USA LLCGLAND PHARMA LTDHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCMEITHEAL PHARMACEUTICALS INCMYLAN INSTITUTIONAL LLCMYLAN LABORATORIES LTDNOVARTIS PHARMACEUTICALS CORPSAGENT PHARMACEUTICALS INCSUN PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS USA INCWEST-WARD PHARMACEUTICALS INTERNATIONAL LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Octreotide drfinder.aiFind doctors who prescribe Octreotide rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Octreotide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.